BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 11015203)

  • 1. Analysis of the RNA-editing reaction of ADAR2 with structural and fluorescent analogues of the GluR-B R/G editing site.
    Stephens OM; Yi-Brunozzi HY; Beal PA
    Biochemistry; 2000 Oct; 39(40):12243-51. PubMed ID: 11015203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine to inosine editing by ADAR2 requires formation of a ternary complex on the GluR-B R/G site.
    Jaikaran DC; Collins CH; MacMillan AM
    J Biol Chem; 2002 Oct; 277(40):37624-9. PubMed ID: 12163487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational changes that occur during an RNA-editing adenosine deamination reaction.
    Yi-Brunozzi HY; Stephens OM; Beal PA
    J Biol Chem; 2001 Oct; 276(41):37827-33. PubMed ID: 11479320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro analysis of the binding of ADAR2 to the pre-mRNA encoding the GluR-B R/G site.
    Ohman M; Källman AM; Bass BL
    RNA; 2000 May; 6(5):687-97. PubMed ID: 10836790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic substrate analogs for the RNA-editing adenosine deaminase ADAR-2.
    Yi-Brunozzi HY; Easterwood LM; Kamilar GM; Beal PA
    Nucleic Acids Res; 1999 Jul; 27(14):2912-7. PubMed ID: 10390533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of mismatch on binding of ADAR2/GluR-2 pre-mRNA complex.
    Yang J; Song J; Zhang JZ; Ji C
    J Mol Model; 2015 Sep; 21(9):222. PubMed ID: 26252972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Fluorescent Adenosine Analogue as a Substrate for an A-to-I RNA Editing Enzyme.
    Mizrahi RA; Shin D; Sinkeldam RW; Phelps KJ; Fin A; Tantillo DJ; Tor Y; Beal PA
    Angew Chem Int Ed Engl; 2015 Jul; 54(30):8713-6. PubMed ID: 26095193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substrate recognition by ADAR1 and ADAR2.
    Wong SK; Sato S; Lazinski DW
    RNA; 2001 Jun; 7(6):846-58. PubMed ID: 11421361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substrate analogues for an RNA-editing adenosine deaminase: mechanistic investigation and inhibitor design.
    Véliz EA; Easterwood LM; Beal PA
    J Am Chem Soc; 2003 Sep; 125(36):10867-76. PubMed ID: 12952466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADAR2 A-->I editing: site selectivity and editing efficiency are separate events.
    Källman AM; Sahlin M; Ohman M
    Nucleic Acids Res; 2003 Aug; 31(16):4874-81. PubMed ID: 12907730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and sequence determinants required for the RNA editing of ADAR2 substrates.
    Dawson TR; Sansam CL; Emeson RB
    J Biol Chem; 2004 Feb; 279(6):4941-51. PubMed ID: 14660658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matching active site and substrate structures for an RNA editing reaction.
    Pokharel S; Jayalath P; Maydanovych O; Goodman RA; Wang SC; Tantillo DJ; Beal PA
    J Am Chem Soc; 2009 Aug; 131(33):11882-91. PubMed ID: 19642681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-stranded RNA adenosine deaminases ADAR1 and ADAR2 have overlapping specificities.
    Lehmann KA; Bass BL
    Biochemistry; 2000 Oct; 39(42):12875-84. PubMed ID: 11041852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA editing in DNA/RNA hybrids by adenosine deaminases that act on RNA.
    Zheng Y; Lorenzo C; Beal PA
    Nucleic Acids Res; 2017 Apr; 45(6):3369-3377. PubMed ID: 28132026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA editing of the Q/R site of GluA2 in different cultured cell lines that constitutively express different levels of RNA editing enzyme ADAR2.
    Yamashita T; Tadami C; Nishimoto Y; Hideyama T; Kimura D; Suzuki T; Kwak S
    Neurosci Res; 2012 May; 73(1):42-8. PubMed ID: 22366356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Base-pairing probability in the microRNA stem region affects the binding and editing specificity of human A-to-I editing enzymes ADAR1-p110 and ADAR2.
    Ishiguro S; Galipon J; Ishii R; Suzuki Y; Kondo S; Okada-Hatakeyama M; Tomita M; Ui-Tei K
    RNA Biol; 2018; 15(7):976-989. PubMed ID: 29950133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant alternative splicing pattern of ADAR2 downregulates adenosine-to-inosine editing in glioma.
    Li Z; Tian Y; Tian N; Zhao X; Du C; Han L; Zhang H
    Oncol Rep; 2015 Jun; 33(6):2845-52. PubMed ID: 25873329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editing of glutamate receptor subunit B pre-mRNA in vitro by site-specific deamination of adenosine.
    Yang JH; Sklar P; Axel R; Maniatis T
    Nature; 1995 Mar; 374(6517):77-81. PubMed ID: 7870177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The binding selectivity of ADAR2's dsRBMs contributes to RNA-editing selectivity.
    Stephens OM; Haudenschild BL; Beal PA
    Chem Biol; 2004 Sep; 11(9):1239-50. PubMed ID: 15380184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine Deaminase That Acts on RNA 3 (ADAR3) Binding to Glutamate Receptor Subunit B Pre-mRNA Inhibits RNA Editing in Glioblastoma.
    Oakes E; Anderson A; Cohen-Gadol A; Hundley HA
    J Biol Chem; 2017 Mar; 292(10):4326-4335. PubMed ID: 28167531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.